Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tom L. Riley
Observed names:
T. Riley,
Tom Riley
Institution:
Information Management Services
Observed institutions:
National Institutes of Health,
Henry Ford Health,
University of Pittsburgh,
Information Management Services,
National Cancer Institute,
Division of Cancer Epidemiology and Genetics
show all 6
ORCID:
0000-0002-9794-2998
Observed ORCID:
0000-0002-9794-2998
OpenAlex ID:
A5063238359
Works
16
Awards
2
Selection Criteria for Lung-Cancer Screening
2013
·
Martin C. Tammemägi
, Hormuzd A. Katki
, et al.
·
New England Journal of Medicine
·
1,116
PDF
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
2013
·
Stephanie A. Kovalchik
, Martin Tammemagi
, et al.
·
New England Journal of Medicine
·
603
PDF
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies
2015
·
Amanda Black
, Wen-Yi Huang
, et al.
·
Reviews on Recent Clinical Trials
·
41
Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
2014
·
Pamela M. Marcus
, Sheryl L. Ogden
, et al.
·
Preventive Medicine
·
12
Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial
2015
·
John Gohagan
, Karen Broski
, et al.
·
Reviews on Recent Clinical Trials
·
11
Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial
2013
·
William G. Hocking
, Martin C. Tammemagi
, et al.
·
Lung Cancer
·
10
Clinical and Genomic Characterization of Interval Colorectal Cancer in 3 Prospective Cohorts
2022
·
Keming Yang
, Yin Cao
, et al.
·
Gastroenterology
·
9
PDF
Data sharing in clinical trials: An experience with two large cancer screening trials
2017
·
Claire S. Zhu
, Paul F. Pinsky
, et al.
·
PLoS Medicine
·
9
PDF
Positive biopsy (bx) rates for prostate cancer (PCA) based on prostate specific antigen (PSA) grouping in a large cancer screening trial: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
2010
·
D. Reding
, C. McCarty
, et al.
·
Journal of Clinical Oncology
·
9
Estimation of Sojourn Time and Transition Probability of Lung Cancer for Smokers using the PLCO Data
2017
·
Dengzhi Wang
, Beth Levitt
, et al.
·
Journal of Biometrics & Biostatistics
·
5
Cohort Profile: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
2025
·
Eric A Miller
, Claire S Zhu
, et al.
·
International Journal of Epidemiology
·
3
Data Processing and Analytic Support in the PLCO Cancer Screening Trial
2015
·
Jerome Mabie
, Tom Riley
, et al.
·
Reviews on Recent Clinical Trials
·
3
Variation in the efficacy of low-dose computed tomographic lung screening based on risk of lung cancer mortality in the National Lung Screening Trial.
2013
·
Hormuzd A. Katki
, Stephanie A Kovalchik
, et al.
·
Journal of Clinical Oncology
·
2
939 Association Between Family History of Colorectal Cancer and Incident Colorectal Cancer in the PLCO Trial
2014
·
Anthony Razzak
, Kelly Yu
, et al.
·
Gastroenterology
Characteristics of men with abnormal prostate-specific antigen (PSA) who had a biopsy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
2010
·
W. G. Hocking
, C. McCarty
, et al.
·
Journal of Clinical Oncology
Repeat screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial
2000
·
Joel L. Weissfeld
, Bruce S. Ling
, et al.
·
Gastroenterology
PDF
Show more works
View as search
Works count:
16
Citation count:
1,833
H-index:
9
I10-index:
6
Year
Topic
Type